01 1Bristol-Myers Squibb Company
02 1Lotte Biologics USA, LLC
03 2Patheon Italia S.p.A.
01 1Elotuzumab
02 3elotuzumab
01 1South Korea
02 3U.S.A
NDC Package Code : 70409-2291
Start Marketing Date : 2016-11-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 83157-2291
Start Marketing Date : 2015-11-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68225-245
Start Marketing Date : 2024-03-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (300mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 68225-246
Start Marketing Date : 2024-03-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (400mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 3 companies offering Elotuzumab
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
